Close
Nordic 9Nordic 9

Van Herk Ventures (investor - Corporate Investor)

Netherlands vanherkgroep.nl
See something wrong or missing? Let us know
Offices:Rotterdam

Van Herk Ventures is an investment arm of the real estate group Van Herk Groep from the Netherlands, investing in both listed and unlisted companies.

Average round investment:5.85M USD
Average number per year:1.5
Distribution: 2024 (2)2023 (1)
Portfolio companies: Netherlands Spatium MedicalNetherlands Pan Cancer
Mostly invests in: Netherlands Netherlands (3) Health services (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Van Herk Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Van Herk Ventures

Name Criteria
Netherlands Delft Enterprises
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Luxembourg i&i Biotech Fund
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands Horticoop
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Erasmus MC
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Adjacent
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
France Truffle Capital
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 3.2
  • Active last 12 months: Yes
United States Dolby Family Ventures
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Netherlands Netherlands Enterprise Agency
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Switzerland SAGANA
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Initialized Capital
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top